• Butler, A.C. & Tait, R.C. (1998) Management of oral anticoagulant-induced intracranial haemorrhage. Blood Reviews, 12, 3544.
  • Gray, E., Tubbs, J., Thomas, S., Oates, A., Boisclair, M., Kemball-Cook, G. & Barrowcliffe, T.W. (1995) Measurement of activated factor IX in factor IX concentrate: correlation with in-vivo thrombogenicity. Thrombosis and Haemostasis, 73, 675679.
  • Kasper, C.K. (1973) Postoperative thromboses in hemophilia B (Letter). New England Journal of Medicine, 289, 160.
  • Kasper, C.K. (1975) Thromboembolic complications – Task Force Report. Thrombosis Diathesis Haemorrhagica, 33, 640644.
  • Köhler, M. (1995) Thrombogenicity of prothrombin complex concentrates. Thrombosis Research, S13S17.
  • Köhler, M., Heiden, M., Harbauer, G., Miyafhita, C., Mörsdorf, S., Braun, B., Ernert, P., Wenzel, E., Rose, S. & Pindur, G. (1990) Comparison of different prothrombin complex concentrates: in-vitro and in-vivo studies. Thrombosis Research, 60, 6370.
  • Lusher, J.M. (1991) Thrombogenicity associated with factor IX complex concentrates. Seminars in Haematology, 28, 35.
  • Makris, M., Greaves, M., Philips, W.S., Kitchen, S., Rosendaal, F.R. & Preston, F.E. (1997) Emergency oral anticoagulant reversal; the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and Haemostasis, 77, 477480.
  • Marlar, R.A., Enders-Brooks, J. & Miller, C. (1985) Serial studies of protein C and its plasma inhibitor in patients with disseminated intravascular coagulation. Blood, 66, 5963.
  • Van Der Meer, S.J.M., Rosendaal, F.R., Van Den Brouke, J.P. & Briet, E. (1993) Bleeding complications in oral anticoagulant therapy. Archives of Internal Medicine, 153, 15571562.
  • Palareti, G., Leali, N., Coccheri, S., Poggi, M., Manotti, C., D'Angelo, A., Pengo, V., Erba, N., Moia, M., Ciavarella, N., Devoto, G., Berrettini, M. & Musolefi, S. (1996) Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian study on complications of oral anticoagulant therapy. Lancet, 348, 423428.
  • Philippou, H., Adami, A., Lane, D.A., MacGregor, I.R., Tuddenham, E.G.D., Lowe, G.D.O., Rumley, A. & Ludlam, C.A. (1996) High purity factor IX and prothrombin complex concentrate (PCC): pharmacokinetics and evidence that factor IXa is the thrombogenic trigger in PCC. Thrombosis and Haemostasis, 76, 2328.
  • Prowse, C.W. & Cash, J.D. (1981) The use of factor IX concentrates in man: a 9 year experience. British Journal of Haematology, 47, 91104.